$TALK
Talkspace, Inc.
CIK:0001803901|SEC Filings
Condensed Consolidated Income Statements (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenues | $ 61,672 | $ 54,310 | $ 123,351 | $ 106,492 |
| Costs and operating expenses: | ||||
| Cost of revenue, excluding depreciation and amortization | 36,869 | 30,917 | 72,933 | 59,706 |
| Research and development | 2,343 | 2,563 | 5,007 | 5,403 |
| Clinical operations | 1,873 | 1,921 | 3,747 | 3,777 |
| Sales and marketing | 14,661 | 14,253 | 28,510 | 28,178 |
| General and administrative | 6,458 | 5,728 | 19,276 | 10,935 |
| Depreciation and amortization | 1,581 | 718 | 3,118 | 1,368 |
| Total costs and operating expenses | 63,785 | 56,100 | 132,591 | 109,367 |
| Loss from operations | (2,113) | (1,790) | (9,240) | (2,875) |
| Financial income, net | (608) | (1,325) | (1,553) | (2,851) |
| Loss before income taxes | (1,505) | (465) | (7,687) | (24) |
| Income tax expense | 11 | 76 | 135 | 199 |
| Net loss | $ (1,516) | $ (541) | $ (7,822) | $ (223) |
| Net loss per share: | ||||
| Basic | $ (0.01) | $ (0) | $ (0.05) | $ (0) |
| Diluted | $ (0.01) | $ (0) | $ (0.05) | $ (0) |
| Weighted average shares used to compute net (loss) income per share: | ||||
| Basic | 167,486,050 | 167,532,721 | 167,281,977 | 168,098,647 |
| Diluted | 167,486,050 | 167,532,721 | 167,281,977 | 168,098,647 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands |
Jun. 30, 2026 |
Dec. 31, 2025 |
||
|---|---|---|---|---|
| CURRENT ASSETS: | ||||
| Cash and cash equivalents | [1] | $ 39,159 | $ 37,352 | |
| Marketable securities | 51,839 | 55,234 | ||
| Accounts receivable, net | [1] | 15,444 | 16,061 | |
| Other current assets | 2,573 | 2,415 | ||
| Total current assets | 109,015 | 111,062 | ||
| Fixed assets, net | 20,053 | 15,794 | ||
| Goodwill | 3,427 | 3,318 | ||
| Other long-term assets | 3,951 | 4,689 | ||
| Total assets | 136,446 | 134,863 | ||
| CURRENT LIABILITIES: | ||||
| Accounts payable | 10,937 | 8,501 | ||
| Accrued expenses and other current liabilities | [1] | 10,468 | 6,672 | |
| Deferred revenues | 2,713 | 2,223 | ||
| Total current liabilities | 24,118 | 17,396 | ||
| Other long-term liabilities | 197 | 452 | ||
| Total liabilities | 24,315 | 17,848 | ||
| Commitments and contingencies (Note 6) | ||||
| STOCKHOLDERS' EQUITY: | ||||
| Common stock of $0.0001 par value per share: Shares authorized: 1,000,000,000 as of June 30, 2026 (unaudited) and December 31, 2025; shares issued and outstanding: 165,823,816 and 166,718,150 as of June 30, 2026 (unaudited) and December 31, 2025, respectively. | 17 | 17 | ||
| Additional paid-in capital | 381,474 | 378,384 | ||
| Accumulated deficit | (269,265) | (261,443) | ||
| Accumulated other comprehensive (loss) income | (95) | 57 | ||
| Total stockholders' equity | 112,131 | 117,015 | ||
| Total liabilities and stockholders' equity | $ 136,446 | $ 134,863 | ||
| ||||